Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria
Stephen T. Abedon
Pharmaceuticals (2015) Vol. 8, Iss. 3, pp. 559-589
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth
Paul Hyman
Pharmaceuticals (2019) Vol. 12, Iss. 1, pp. 35-35
Open Access | Times Cited: 414
Ecology of the Oral Microbiome: Beyond Bacteria
Jonathon L. Baker, Batbileg Bor, Melissa Agnello, et al.
Trends in Microbiology (2017) Vol. 25, Iss. 5, pp. 362-374
Open Access | Times Cited: 296
Anti-biofilm Activity as a Health Issue
Sylvie Miquel, Rosyne Lagrafeuille, Bertrand Souweine, et al.
Frontiers in Microbiology (2016) Vol. 7
Open Access | Times Cited: 200
Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
Barbara Maciejewska, Tomasz Olszak, Zuzanna Drulis‐Kawa
Applied Microbiology and Biotechnology (2018) Vol. 102, Iss. 6, pp. 2563-2581
Open Access | Times Cited: 194
Editorial: Phage Therapy: Past, Present and Future
Stephen T. Abedon, Pilar García, Peter Mullany, et al.
Frontiers in Microbiology (2017) Vol. 8
Open Access | Times Cited: 190
Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments
Rocío Trastoy, Teresa Manso, Laura Fernández-García, et al.
Clinical Microbiology Reviews (2018) Vol. 31, Iss. 4
Open Access | Times Cited: 151
An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms
Maneesha K. Suresh, Raja Biswas, Lalitha Biswas
International Journal of Medical Microbiology (2018) Vol. 309, Iss. 1, pp. 1-12
Closed Access | Times Cited: 139
Phage mobility is a core determinant of phage–bacteria coexistence in biofilms
Emilia L. Simmons, Knut Drescher, Carey D. Nadell, et al.
The ISME Journal (2017) Vol. 12, Iss. 2, pp. 532-543
Open Access | Times Cited: 131
Biofilm formation by Salmonella sp. in the poultry industry: Detection, control and eradication strategies
Lina Merino, Francisco Procura, Fernando M. Trejo, et al.
Food Research International (2017) Vol. 119, pp. 530-540
Open Access | Times Cited: 130
Phage Therapy with a Focus on the Human Microbiota
Sharita Divya Ganeshan, Zeinab Hosseinidoust
Antibiotics (2019) Vol. 8, Iss. 3, pp. 131-131
Open Access | Times Cited: 126
The use of bacteriophages to biocontrol oral biofilms
Szymon P. Szafrański, Andreas Winkel, Meike Stiesch
Journal of Biotechnology (2017) Vol. 250, pp. 29-44
Open Access | Times Cited: 106
In vitro and in vivo biofilm forming Vibrio spp: A significant threat in aquaculture
Manivel Arunkumar, Felix LewisOscar, Nooruddin Thajuddin, et al.
Process Biochemistry (2020) Vol. 94, pp. 213-223
Closed Access | Times Cited: 99
A combination therapy of Phages and Antibiotics: Two is better than one
Xianghui Li, Yuhua He, Zhili Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3573-3582
Open Access | Times Cited: 97
Bacterial resistance to antimicrobial agents and its impact on veterinary and human medicine
Štefan Schwarz, Anette Loeffler, Kristina Kadlec
Veterinary Dermatology (2016) Vol. 28, Iss. 1, pp. 82-82
Open Access | Times Cited: 91
Bacteriophage exploitation of bacterial biofilms: phage preference for less mature targets?
Stephen T. Abedon
FEMS Microbiology Letters (2016) Vol. 363, Iss. 3, pp. fnv246-fnv246
Open Access | Times Cited: 86
Coming-of-Age Characterization of Soil Viruses: A User’s Guide to Virus Isolation, Detection within Metagenomes, and Viromics
Gareth Trubl, Paul Hyman, Simon Roux, et al.
Soil Systems (2020) Vol. 4, Iss. 2, pp. 23-23
Open Access | Times Cited: 84
Biological challenges of phage therapy and proposed solutions: a literature review
Katherine M. Caflisch, Gina A. Suh, Robin Patel
Expert Review of Anti-infective Therapy (2019) Vol. 17, Iss. 12, pp. 1011-1041
Open Access | Times Cited: 81
Biofilm control by interfering with c-di-GMP metabolism and signaling
Xiaobo Liu, Bin Cao, Liang Yang, et al.
Biotechnology Advances (2022) Vol. 56, pp. 107915-107915
Closed Access | Times Cited: 69
Bacteriophage Adsorption: Likelihood of Virion Encounter with Bacteria and Other Factors Affecting Rates
Stephen T. Abedon
Antibiotics (2023) Vol. 12, Iss. 4, pp. 723-723
Open Access | Times Cited: 31
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections
Nikki Tran, Taylor Morrisette, Sarah C J Jorgensen, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 8, pp. 816-832
Open Access | Times Cited: 29
Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms
Razieh Kebriaei, Susan M. Lehman, Rahi M. Shah, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 23
Phage Life Cycles Behind Bacterial Biodiversity
Tomasz Olszak, Agnieszka Łątka, Bartosz Roszniowski, et al.
Current Medicinal Chemistry (2017) Vol. 24, Iss. 36
Open Access | Times Cited: 82
Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages
Stephen T. Abedon
Pharmaceuticals (2015) Vol. 8, Iss. 3, pp. 525-558
Open Access | Times Cited: 78
Phage “delay” towards enhancing bacterial escape from biofilms: a more comprehensive way of viewing resistance to bacteriophages
Stephen T. Abedon
AIMS Microbiology (2017) Vol. 3, Iss. 2, pp. 186-226
Open Access | Times Cited: 75
Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections
Stephen T. Abedon
Advanced Drug Delivery Reviews (2018) Vol. 145, pp. 18-39
Closed Access | Times Cited: 74
Page 1 - Next Page

Scroll to top